Guest blog by Marie Apodaca, LE&RN Colorado Chapter Chair. Pictured above: Marie and Dennis at 2017 CA #LymphWalk.

Hi All,

I just found out that Dennis Schlaht will be awarded the LE&RN Advocate Award at the 4th annual CA Run/Walk to Fight Lymphedema & Lymphatic Diseases in Santa Monica

To attend this free on-line Symposium on Prevention of Breast Cancer Related Lymphedema with Sheldon Marc Feldman, M.D., F.A.C.S., simply visit our Livestream event page at https://livestream.com/LymphaticRF/Feldman on July 23 at 11am EDT, 10am CDT, 9am MDT, 8am PDT.

Click here for the online release and a downloadable pdf.

SANTA MONICA, CA – June 14, 2018 – Oceanfront Walk (2000 Ocean Avenue) in Santa Monica will be a sea of teal on June 24 as lymphedema and lymphatic disease advocates gather for their annual 5K Run/Walk to raise awareness and funding

Pictured above: Colorado LymphWalk Speaker Allyson Hannah.

Click here for the online release and a downloadable pdf.

DENVER, CO – May 25, 2018 – Join the Colorado Chapter of the Lymphatic Education & Research Network (LE&RN) for the second annual Colorado Run/Walk to Fight Lymphedema &

Seon Pyo Hong received a 2018 LE&RN Poster Award at the Gordon Research Conference (GRC) on Lymphatics Forum in Italy, March 2018. We asked Dr. Hong to share with our Supporting Members some thoughts on his career, on lymphatic research, and on the GRC. Supporting Members make LE&RN research

A guest blog post by Annalisa Zecchin, PhD, 2018 GRC Travel Award Winner.

My name is Annalisa Zecchin, I’m a postdoctoral fellow at the Center for Cancer Biology, VIB-KULeuven (Leuven, Belgium) under the supervision of Prof. Dr. Peter Carmeliet. I was awarded a LE&RN Travel Award in 2018 to

I began Stage One LE in my thighs after being diagnosed in 1986 with Congestive Heart Failure. But, the doctors didn't know what it was back then. Then, got Breast cancer about 15 years ago, and it went from my upper arms to also calves, and ankles and often feet. Diagnosed as cellulitis and

Pekka Simula is the CEO of Herantis Pharma Plc (HRTIS:FN), a public drug development company based in Finland with focus on regenerative medicine based on leading science. Simula is also Chairman for Finnish Bioindustries. Simula has previously worked e.g. as founding CEO of Oncos